RE 19 (Atenolol 25 mg)

Pill imprint RE 19 has been identified as Atenolol 25 mg.

Atenolol is used in the treatment of anxiety; high blood pressure; alcohol withdrawal; angina; supraventricular tachycardia (and more), and belongs to the drug class cardioselective beta blockers. There is positive evidence of human fetal risk during pregnancy. Atenolol 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for RE 19

Atenolol 25 mg RE 19 Front
Atenolol 25 mg RE 19 Back
Atenolol 25 mg RE 19
Atenolol
Imprint:
RE
19
Strength:
25 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Cardioselective beta blockers
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Ranbaxy Pharmaceuticals Inc.
National Drug Code (NDC):
63304-0621
Inactive Ingredients:
magnesium carbonate
magnesium stearate
silicon dioxide colloidal
sodium lauryl sulfate
sodium starch glycolate type A potato
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
21695-0322 Rebel Distributors Corp (repackager)
53002-1108 Pharmedix (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)